← Evidence map

ArticleWorld journal of gastrointestinal pharmacology and therapeutics2026

Letter to the Editor: Can upadacitinib dose escalation redefine treatment strategies in refractory inflammatory bowel disease?

Himanshu Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42707821